Luxiq
Loading...Luxiq Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
FLAMMABLE. AVOID FIRE, FLAME OR SMOKING DURING AND IMMEDIATELY FOLLOWING APPLICATION. Keep out of reach of children. Contents under pressure. Do not puncture or incinerate container. Do not expose to heat or store at temperatures above 120°F (49°C).
Manufactured for
Stiefel Laboratories, Inc.
Coral Gables, FL 33134
USA
For additional information visit www.luxiq.com
Questions? Call 1-888-500-DERM (3376). Side effects may be reported to this number.
303203
P/N: xxxxxxxx
Lixuq, VersaFoam-HF, VersaFoam-HF & Design, Stiefel, and Stiefel & Design are registered trademarks of Stiefel Laboratories, Inc.
©2009 Stiefel Laboratories, Inc.
Relabeling of "Additional" barcode label by:
Physicians Total Care, Inc.
Tulsa, OK 74146
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Luxíq is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.
History
There is currently no drug history available for this drug.
Other Information
Luxíq Foam contains betamethasone valerate, USP, a synthetic corticosteroid, for topical dermatologic use. The corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory agents.
Betamethasone valerate is 9-fluoro11ß,17, 21-trihydroxy-16ß-methylpregna-1, 4-diene-3, 20-dione 17-valerate, with the empirical formula C27H37FO6, a molecular weight of 476.58.The following is the chemical structure:
Betamethasone valerate is a white to practically white, odorless crystalline powder, and is practically insoluble in water, freely soluble in acetone and in chloroform, soluble in alcohol, and slightly soluble in benzene and in ether.
Luxíq® (betamethasone valerate) Foam, 0.12%, contains 1.2 mg betamethasone valerate, USP, per gram in a thermolabile hydroethanolic foam vehicle consisting of cetyl alcohol, citric acid, ethanol (60.4%), polysorbate 60, potassium citrate, propylene glycol, purified water, and stearyl alcohol pressurized with a hydrocarbon (propane/butane) propellant.
Sources
Luxiq Manufacturers
-
Physicians Total Care, Inc.
![Luxiq (Betamethasone Valerate) Aerosol, Foam [Physicians Total Care, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Luxiq | Physicians Total Care, Inc.
Note: For proper dispensing of foam, can must be inverted.
For application to the scalp invert can and dispense a small amount of Luxíq onto a saucer or other cool surface. Do not dispense directly onto hands as foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of foam with fingers and gently massage into affected area until foam disappears. Repeat until entire affected scalp area is treated. Apply twice daily, once in the morning and once at night.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
Luxíq should not be used with occlusive dressings unless directed by a physician.
-
Stiefel Laboratories Inc
Luxiq | Stiefel Laboratories Inc
Note: For proper dispensing of foam, can must be inverted.
For application to the scalp invert can and dispense a small amount of Luxíq onto a saucer or other cool surface. Do not dispense directly onto hands as foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of foam with fingers and gently massage into affected area until foam disappears. Repeat until entire affected scalp area is treated. Apply twice daily, once in the morning and once at night.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
Luxíq should not be used with occlusive dressings unless directed by a physician.
-
Prestium Pharma, Inc.
Luxiq | Prestium Pharma, Inc.
Note: For proper dispensing of foam, can must be inverted.
For application to the scalp invert can and dispense a small amount of Luxíq onto a saucer or other cool surface. Do not dispense directly onto hands as foam will begin to melt immediately upon contact with warm skin. Pick up small amounts of foam with fingers and gently massage into affected area until foam disappears. Repeat until entire affected scalp area is treated. Apply twice daily, once in the morning and once at night.
As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
Luxíq should not be used with occlusive dressings unless directed by a physician.
![Luxiq (Betamethasone Valerate) Aerosol, Foam [Stiefel Laboratories Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=02b6cc3c-3aec-47dc-8936-fdc7ce8bdb55&name=6094e3c6-ba85-4774-a61d-233f92b92c6c-03.jpg)
![Luxiq (Betamethasone Valerate) Aerosol, Foam [Prestium Pharma, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=51fe8c40-5e56-4449-8995-f227c8bb5a50&name=luxiq-5.jpg)
Login To Your Free Account